Consecuencias de la Biología Sintética en los Derechos de Propiedad Intelectual y Acceso a los Recursos Genéticos y Distribución de los Beneficios (Implications of Synthetic Biology in Intellectual Property Rights and Access to Genetic Resources and Benefit-Sharing)
La Propiedad Inmaterial, No. 16, p. 281, November 2012
15 Pages Posted: 28 Nov 2012
Date Written: September 2, 2012
Synthetic biology is a new technology that represents a shift from exploitation of genetic resources to lab production of synthetic biological entitles. As a consequence of this transition, synthetic biology will potentially eradicate the interest in genetic resources located in developing countries. This will lead to pharmaceutical and biotechnology companies to not recognize any benefit sharing as it is established by the Convention on Biological Diversity (CBD). The disruptive character that synthetic biology involves could be even greater if intellectual property rights (IPR) create barriers to accessing new synthetic biological inventions. This paper explores the impact that synthetic biology will have in the regulation on access to genetic resources and benefit sharing under the CBD and IPR.
Note: Downloadable document is in Spanish.
Keywords: synthetic biology, intellectual property rights, access to genetic resources, benefit sharing, Convention on Biological Diversity
Suggested Citation: Suggested Citation